Celsion

Imunon creates proprietary immunology and DNA-based technology for difficult-to-treat conditions. We are scientists, researchers, and innovators who believe in the power of immunology and DNA as the building block for health and well-being, and we’re just getting started. Imunon is led by an experienced, innovative, and capital-savvy management team with a track record of bringing products to market at global brands like Amgen, Moderna, Roche, Valentis, Novavax, and more. We Are Bold And Determined To Take On Challenges. We are a team of dedicated scientists and innovators working together to overcome barriers and advance scientific discoveries. IMUNON is developing new medicines that harness the building blocks of life to work in harmony with the body’s immune system. Church joined Imunon in July 2010 as Vice President and Chief Financial Officer. Our innovative DNA platforms instruct the body’s immune system to create potent responses when and where they’re needed.